Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Mind Medicine Mindmed Inc (NQ: MNMD )

6.140 -0.160 (-2.54%)
Streaming Delayed Price Updated: 4:00 PM EDT, Nov 1, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Mind Medicine Mindmed Inc

< Previous 1 2
...
10 11 12 13 14 15 16 17 18
...
31 32 Next >
Psychedelic Stock Gainers And Losers From November 30, 2022
Via Benzinga
Revive Therapeutics, Seelos Therapeutics Among Top Psychedelic Movers Of Today
Via Benzinga
Revive Therapeutics, Compass Pathways Among Top Psychedelic Movers Of Today
Via Benzinga
7 F-Rated Stocks to Sell Before We Reach Christmas
While you’re looking for the perfect holiday bargains, this is also an ideal time to clear your portfolio from F-rated stocks to sell. 
Via InvestorPlace
Psychedelic Stock Gainers And Losers From November 25, 2022
Via Benzinga
Mind Medicine’s Bad Trip Won’t End Anytime Soon
Trouble abounds as Mind Medicine proposes a huge sale of MNMD stock shares and an activist investor threatens the company's board. 
Via InvestorPlace
Psychedelic Stock Gainers And Losers From November 24, 2022
Via Benzinga
Psychedelic Stock Gainers And Losers From November 23, 2022
Via Benzinga
Psychedelic Stock Gainers And Losers From November 22, 2022
Via Benzinga
Psychedelic Stock Gainers And Losers From November 21, 2022
Via Benzinga
Psychedelic Drug Stocks Index Continued To Decline Last Week
This article highlights the performances of the 6 constituents in the munKNEE Psychedelic Drug Stocks Index last week and in the last 3 weeks and the extent to which each company is likely to encounter... 
Via Talk Markets
Biomind Labs, ATAI Life Sciences Among Top Psychedelic Movers Of Today
Via Benzinga
Revive Therapeutics, GH Research Among Top Psychedelic Movers Of Today
Via Benzinga
Psychedelic Stock Gainers And Losers From November 16, 2022
Via Benzinga
GH Research, Seelos Therapeutics Among Top Psychedelic Movers Of Today
Via Benzinga
Psyched: Colorado Legalizes Psychedelics, NYC Treats Alcoholism With Ketamine, $30M Series A For Startup
Colorado Voters Approve Initiative To Legalize And Regulate Psychedelics 
Via Benzinga
Activist Investor Informs MindMed of Financial Misstatements, Questions Internal Controls
From Concerned Shareholders of Company MindMed
Via GlobeNewswire
Benzinga's Top Ratings Upgrades, Downgrades For November 16, 2022
Upgrades 
Via Benzinga
Clinical Stage Psychedelic Stock Index Up 6%; Therapy Clinic Stocks Down 8%
We highlight the performance of our Psychedelic Drug Stocks Index and the 6 psychedelic stocks that research the treatment of a variety of mental illnesses based on the use of different psychedelic... 
Via Talk Markets
MindMed's Q3 2022 Financials & Business, Setting The Stage For Phase 3 Trials
Clinical-stage biotech company Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) reported its financial results and updated on its programs pipeline of the third quarter ended September 30, 2022. 
Via Benzinga
Compass Pathways, Mind Medicine Among Top Psychedelic Movers Of Today
GAINERS: Compass Pathways (NASDAQ:CMPS) shares closed up 12.17% at $10.05 
Via Benzinga
Seelos Therapeutics, GH Research Among Top Psychedelic Movers Of Today
GAINERS: GH Research (NASDAQ:GHRS) shares closed up 7.91% at $9.96 LOSERS: 
Via Benzinga
Psychedelic Stock Gainers And Losers From November 8, 2022
GAINERS: Small Pharma (OTC:DMTTF) shares closed up 3.85% at $0.14 
Via Benzinga
The Psychedelic Drug Stocks Index Continued To Plummet Last Week
In total, the Psychedelic Drug Stock Index went down 5.8% last week and is now down 64.9% YTD. 
Via Talk Markets
Compass Pathways, Allied Among Top Psychedelic Movers Of Today
GAINERS: Allied (OTC:ALID) shares closed up 4.10% at $0.44 
Via Benzinga
Psychedelic Stock Gainers And Losers From November 3, 2022
GAINERS: Compass Pathways (NASDAQ:CMPS) shares closed up 4.80% at $10.27 
Via Benzinga
Psyched Wellness is The First Public Company To Bring Amanita Muscaria For Human Consumption To The U.S.
Easily identified by its red cap covered with white dots and a white stem, the Amanita muscaria mushroom is probably the most famous and easily recognizable mushroom in the world. Popularized by Lewis... 
Via Benzinga
Significant MindMed Investor Demands Federal Investigation to Probe Serious Allegations of Misconduct
From Concerned Shareholders of Company MindMed
Via GlobeNewswire
Compass Pathways, Small Pharma Among Top Psychedelic Movers Of Today
GAINERS: GH Research (NASDAQ:GHRS) shares closed up 3.90% at $10.39 LOSERS: 
Via Benzinga
7 Speculative Penny Stocks Under $3 That Deserve Your Attention in Nov.
While penny stocks are highly speculative and risky, you may still want to consider these seven opportunities. 
Via InvestorPlace
< Previous 1 2
...
10 11 12 13 14 15 16 17 18
...
31 32 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.